A mutation in the iron-responsive element of ALAS2 is a modifier of disease severity in a patient suffering from CLPX associated erythropoietic protoporphyria.

Like Comment
Not available.

View the full article @ Haematologica

Get PDF with LibKey
Authors: Sarah Ducamp, Sara Luscieti, Xènia Ferrer-Cortès, Gaël Nicolas, Hana Manceau, Katell Peoc'h, Yvette Y Yien, Caroline Kannengiesser, Laurent Gouya, Herve Puy, Mayka Sanchez


The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
6577 Contributions
0 Following